OBJECTIVE: To investigate the clinical correlates of central nervous system alterations among women with vulvodynia. Altered central sensitization has been linked to dysfunction in central nervous system-inhibitory pathways (e.g., γ-aminobutyric acidergic), and metrics of sensory adaptation, a centrally mediated process that is sensitive to this dysfunction, could potentially be used to identify women at risk of treatment failure using conventional approaches. METHODS: Twelve women with vulvodynia and 20 age-matched controls participated in this study, which was conducted by sensory testing of the right hand's index and middle fingers. The following sensory precepts were assessed: (1) vibrotactile detection threshold; (2) amplitude discrimination capacity (defined as the ability to detect differences in intensity of simultaneously delivered stimuli to 2 fingers); and (3) a metric of adaptation (determined by the impact that applying conditioning stimuli have on amplitude discriminative capacity). RESULTS: Participants did not differ on key demographic variables, vibrotactile detection threshold, and amplitude discrimination capacity. However, we found significant differences from controls in adaptation metrics in 1 subgroup of vulvodynia patients. Compared with healthy controls and women with a shorter history of pain [n=5; duration (y) = 3.4 ± 1.3], those with a longer history [n=7; duration (y) = 9.3 ± 1.4)] were found to be less likely to have adaptation metrics similar to control values. DISCUSSION: Chronic pain is thought to lead to altered central sensitization, and adaptation is a centrally mediated process that is sensitive to this condition. This report suggests that similar alterations exist in a subgroup of vulvodynia patients.
OBJECTIVE: To investigate the clinical correlates of central nervous system alterations among women with vulvodynia. Altered central sensitization has been linked to dysfunction in central nervous system-inhibitory pathways (e.g., γ-aminobutyric acidergic), and metrics of sensory adaptation, a centrally mediated process that is sensitive to this dysfunction, could potentially be used to identify women at risk of treatment failure using conventional approaches. METHODS: Twelve women with vulvodynia and 20 age-matched controls participated in this study, which was conducted by sensory testing of the right hand's index and middle fingers. The following sensory precepts were assessed: (1) vibrotactile detection threshold; (2) amplitude discrimination capacity (defined as the ability to detect differences in intensity of simultaneously delivered stimuli to 2 fingers); and (3) a metric of adaptation (determined by the impact that applying conditioning stimuli have on amplitude discriminative capacity). RESULTS:Participants did not differ on key demographic variables, vibrotactile detection threshold, and amplitude discrimination capacity. However, we found significant differences from controls in adaptation metrics in 1 subgroup of vulvodyniapatients. Compared with healthy controls and women with a shorter history of pain [n=5; duration (y) = 3.4 ± 1.3], those with a longer history [n=7; duration (y) = 9.3 ± 1.4)] were found to be less likely to have adaptation metrics similar to control values. DISCUSSION: Chronic pain is thought to lead to altered central sensitization, and adaptation is a centrally mediated process that is sensitive to this condition. This report suggests that similar alterations exist in a subgroup of vulvodyniapatients.
Authors: Zheng Zhang; Vinay Tannan; Jameson K Holden; Robert G Dennis; Mark Tommerdahl Journal: Biomed Eng Online Date: 2008-03-10 Impact factor: 2.819
Authors: Richard H Nguyen; Bryan Kirsch; Roger Yu; Suha Shim; Peter Mangum; Jameson K Holden; Eric M Francisco; Mark Tommerdahl Journal: J Undergrad Neurosci Educ Date: 2013-06-15
Authors: Sam Lowe; Anna Tommerdahl; Rachael Lensch; Eric Francisco; Jameson Holden; Mark Tommerdahl Journal: J Undergrad Neurosci Educ Date: 2016-04-15
Authors: Richard H Nguyen; Theresa M Forshey; Jameson K Holden; Eric M Francisco; Bryan Kirsch; Oleg Favorov; Mark Tommerdahl Journal: Exp Brain Res Date: 2014-07-31 Impact factor: 1.972
Authors: Maria T Chao; Priscilla D Abercrombie; Sanae Nakagawa; Steven E Gregorich; Lee A Learman; Miriam Kuppermann Journal: Pain Med Date: 2014-10-03 Impact factor: 3.750
Authors: Jameson K Holden; Richard H Nguyen; Eric M Francisco; Zheng Zhang; Robert G Dennis; Mark Tommerdahl Journal: J Neurosci Methods Date: 2011-12-04 Impact factor: 2.390
Authors: Arpana Gupta; Davis C Woodworth; Benjamin M Ellingson; Andrea J Rapkin; Bruce Naliboff; Lisa A Kilpatrick; Jean Stains; Salome Masghati; Kirsten Tillisch; Emeran A Mayer; Jennifer S Labus Journal: J Pain Date: 2018-01-31 Impact factor: 5.820
Authors: David C Foster; Megan L Falsetta; Collynn F Woeller; Stephen J Pollock; Kunchang Song; Adrienne Bonham; Constantine G Haidaris; Chris J Stodgell; Susan P Messing; Michael Iadarola; Richard P Phipps Journal: Pain Date: 2015-03 Impact factor: 7.926
Authors: Zheng Zhang; Eric M Francisco; Jameson K Holden; Robert G Dennis; Mark Tommerdahl Journal: Front Aging Neurosci Date: 2011-12-08 Impact factor: 5.750